Jump to content

20250152576. Injectable Formulation Comprisin (LG CHEM, LTD.): Difference between revisions

From WikiPatents
Automated patent report
 
Automated patent report
 
Line 20: Line 20:


<!-- JSON-LD markup for search engines:
<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250152576. Injectable Formulation Comprisin (LG CHEM, LTD.)","name":"20250152576. Injectable Formulation Comprisin (LG CHEM, LTD.)","description":"Patent application abstract and classification for 20250152576 - Injectable Formulation Comprisin","datePublished":"2025-05-22","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250152576","name":"Injectable Formulation Comprisin","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"LG CHEM, LTD."}]}}
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250152576. Injectable Formulation Comprisin (LG CHEM, LTD.)","name":"20250152576. Injectable Formulation Comprisin (LG CHEM, LTD.)","description":"Patent application abstract and classification for 20250152576 - Injectable Formulation Comprisin","datePublished":"2025-05-23","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250152576","name":"Injectable Formulation Comprisin","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"LG CHEM, LTD."}]}}
-->
-->

Latest revision as of 01:48, 23 May 2025

INJECTABLE FORMULATION COMPRISING ISOXAZOLINE DERIVATIVE AND METHOD FOR PREPARING SAME

Abstract: the present invention relates to a pharmaceutical formulation for injection comprising an isoxazoline derivative useful as a caspase inhibitor or a pharmaceutically acceptable salt thereof as an active pharmaceutical ingredient (api). the pharmaceutical formulation for injection according to the present invention includes the first formulation composed of a high-dose api and the second formulation including a reconstitution solution, so that it can be prepared by mixing the first formulation and the second formulation immediately before administration to a patient, and contains the active-api stably. therefore, there is an advantage that effective drug efficacy can be expected when administered to a patient.

Inventor(s): Jaeuk BAEK, Sung Won KIM, Jung Woon YOON

CPC Classification: A61K31/4725 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250152576


Cookies help us deliver our services. By using our services, you agree to our use of cookies.